Skip to main content Accessibility help
×
Hostname: page-component-7d684dbfc8-26pbs Total loading time: 0 Render date: 2023-09-22T09:06:01.326Z Has data issue: false Feature Flags: { "corePageComponentGetUserInfoFromSharedSession": true, "coreDisableEcommerce": false, "coreDisableSocialShare": false, "coreDisableEcommerceForArticlePurchase": false, "coreDisableEcommerceForBookPurchase": false, "coreDisableEcommerceForElementPurchase": false, "coreUseNewShare": true, "useRatesEcommerce": true } hasContentIssue false

Section IV - Iatrogenic hemorrhagic strokes: thrombolysis-related hemorrhagic strokes

Published online by Cambridge University Press:  20 October 2016

Alexander Tsiskaridze
Affiliation:
Sarajishvili Institute of Neurology, Tblisi State University, Georgia
Arne Lindgren
Affiliation:
Department of Neurology, University Hospital Lund, Sweden
Adnan I. Qureshi
Affiliation:
Department of Neurology, University of Minnesota
Get access
Type
Chapter
Information
Treatment-Related Stroke
Including Iatrogenic and In-Hospital Strokes
, pp. 155 - 168
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–7.
Hacke, W, Kaste, M, Fieschi, C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352:1245–51.
Hacke, W, Kaste, M, Bluhmki, E, et al. ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359(13):1317–29.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997; 28:2109–18.
Fiorelli, M, Bastianello, S, von Kummer, R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999; 30:2280–4.
del Zoppo, G J, Higashida, R T, Furlan, A J, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998; 29:411.
Furlan, A, Higashida, R, Wechsler, L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282:2003–11.
IMS Study Investigators. Combined intravenous and intraarterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke. 2004; 35:904–11.
IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007; 38:2127–35.
Smith, W S, Sung, G, Starkman, S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005; 36:1432–8.
Smith, W S, Sung, G, Saver, J, et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke. 2008; 39:1205–12.
Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009; 40:2761–8.
Saver, J L, Jahan, R, Levy, E I, et al. SWIFT Trialists. Solitaire Flow Restoration Device versus the Merci Retriever in Patients with Acute Ischaemic Stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet. 2012; 380(9849):1241–9.
Nogueira, R G, Lutsep, H L, Gupta, R, et al. TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet. 2012; 380(9849):1231–40.
Broderick, J P, Palesch, Y Y, Demchuk, A M, et al. Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 368(10):893903.
Berkhemer, O A, Fransen, P S, Beumer, D, et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 372(1):1120.
Goyal, M, Demchuk, A M, Menon, B K, et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372(11):1019–30.
Campbell, B C, Mitchell, P J, Kleinig, T J, et al. EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 372(11):1009–18.
Alexandrov, A V, Black, S E, Ehrlich, L E, Caldwell, C B, Norris, J W. Predictors of hemorrhagic transformation occurring spontaneously and on anticoagulants in patients with acute ischemic stroke. Stroke. 1997; 28:1198–202.
Wang, X, Lo, E H. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003; 28:229–44.
Gasche, Y, Copin, J C, Sugawara, T, Fujimura, M, Chan, P H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood–brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2001; 21:1393–400.
Khatri, R, Khatri, P, Khoury, J, et al. Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk. J Neurointerv Surg. 2010; 2:115–19.
Demchuk, A M, Morgenstern, L B, Krieger, D W, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999; 30:34–9.
Natarajan, S K, Dandona, P, Karmon, Y, et al. Prediction of adverse outcomes by blood glucose level after endovascular therapy for acute ischemic stroke. Clinical Article J Neurosurg. 2011; 114:1785–99.
Molina, C A, Alvarez-Sabin, J, Montaner, J, et al. Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke. 2002; 33:1551–6.
Dubey, N, Bakshi, R, Wasay, M, Dmochowski, J. Early computed tomography hypodensity predicts hemorrhage after intravenous tissue plasminogen activator in acute ischemic stroke. J Neuroimaging. 2001; 11:184–8.
Barber, P A, Demchuk, A M, Zhang, J, Buchan, A M. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000; 355:1670–4.
Dzialowski, I, Hill, M D, Coutts, S B, et al. Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke. 2006; 37:973–8.
Hill, M D, Rowley, H A, Adler, F, et al. PROACT-II Investigators. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003; 34:1925–31.
Hill, M D, Demchuk, A M, Tomsick, T A, Palesch, Y Y, Broderick, J P. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. Am J Neuroradiol. 2006; 27:1612–16.
Hill, M D, Demchuk, A M, Goyal, M, et al. IMS3 Investigators. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014; 45(2):444–9.
Whiteley, W N, Slot, K B, Fernandes, P, Sandercock, P, Wardlaw, J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke. 2012; 43(11):2904–9.
Henninger, N, Lin, E, Baker, S P, et al. Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion. Cerebrovasc Dis. 2012; 33(6):525–31.
Orrison, W W Jr, Snyder, K V, Hopkins, L N, et al. Whole-brain dynamic CT angiography and perfusion imaging. Clin Radiol. 2011; 66:566–74.
Gasparotti, R, Grassi, M, Mardighian, D, et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: Predictive value of infarct core size on clinical outcome. Am J Neuroradiol. 2009; 30:722–7.
Bhatt, A, Vora, N A, Thomas, A J, et al. Lower pre-treatment cerebral blood volume increases hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery. 2008; 63:874–9.
Liebeskind, D S, Tomsick, T A, Foster, L D, et al. IMS III Investigators. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014;45(3):759–64.
Kidwell, C S, Chalela, J A, Saver, J L, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA. 2004; 292:1823–30.
Kakuda, W, Thijs, V N, Lansberg, M G, et al. DEFUSE Investigators. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology. 2005; 65:1175–8.
Fiehler, J, Albers, G W, Boulanger, J M, et al. MR Stroke Group. Bleeding risk analysis in stroke imaging before thrombolysis. Stroke. 2007; 38:2738–44.
Soo, Y O, Siu, D Y, Abrigo, J, et al. Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke. 2012; 43(6):1532–6.
Shi, Z S, Loh, Y, Liebeskind, D S, Saver, J L, et al. Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke. 2012; 43(7):1806–11.
del Zoppo, G J, von Kummer, R, Hamann, G F. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. JNNP. 1998; 65:19.
Warach, S, Latour, L L. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood–brain barrier disruption. Stroke. 2004; 35(suppl I):2659–61.
Lansberg, M G, Thijs, V N, Bammer, R, et al. DEFUSE Investigators. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. 2007; 38:2275–8.
Singer, O C, Kurre, W, Humpich, M C, et al. MR Stroke Study Group Investigators. Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke. 2009; 40(8):2743–8.
Deguchi, I, Dembo, T, Fukuoka, T, et al. Usefulness of MRA-DWI mismatch in neuroendovascular therapy for acute cerebral infarction. Eur J Neurol. 2012; 19(1):114–20.
Yoon, W, Seo, J J, Kim, J K, et al. Contrast enhancement and contrast extravasation on computed tomography after intra-arterial thrombolysis in patients with acute ischemic stroke. Stroke. 2004; 35:876–81.
Broderick, J, Connolly, S, Feldmann, E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke. 2007; 38:2001–23.
Mokin, M, Kass-Hout, T, Kass-Hout, O, Zivadinov, R, Mehta, B. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2012; 21(8):852–9.
Ko, Y, Park, J H, Yang, M H, et al. The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke. Stroke. 2010; 41:2512–18.
Goldstein, J N, Marrero, M, Masrur, S, et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage. Arch Neurol. 2010; 67:965–9.
Mendelow, A D, Gregson, B A, Fernandes, H M, et al. STICH investigators. Early versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet. 2005; 365:387–97.
Williams, A, Sittampalam, M, Barua, N, Mohd Nor, A. Case series of post-thrombolysis patients undergoing hemicraniectomy for malignant anterior circulation ischaemic stroke. Cardiovasc Psychiatry Neurol. 2011; 254569.
Alshekhlee, A, Horn, C, Jung, R, Alawi, A A, Cruz-Flores, S. In-hospital mortality in acute ischemic stroke treated with hemicraniectomy in US hospitals. J Stroke Cerebrovasc Dis. 2011; 20:196201.
Fargen, K M, Hoh, B L, Fautheree, G L, et al. Aggressive intervention to treat a young woman with intracranial hemorrhage following unsuccessful intravenous thrombolysis for left middle cerebral artery occlusion. Case report. J Neurosurg. 2011; 115:359–63.

References

The National Institute of Neurological Disorders and Stroke tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581–7.
Hacke, W, Kaste, M, Fieschi, C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 13:1017–25.
Hacke, W, Kaste, M, Fieschi, C, et al. Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352:1245–51.
Hacke, W, Donnan, G, Fieschi, C, et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363:768–74.
Hacke, W, Kaste, M, Bluhmki, E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359:1317–29.
Albers, G W, Clark, W M, Madden, K P, Hamilton, S A. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke. 2002; 33:493–5.
Wahlgren, N, Ahmed, N, Eriksson, N, et al. Safe Implementation of Thrombolysis in Stroke-Monitoring Study Investigators. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-Monitoring STudy (SITS-MOST). Stroke. 2008; 3316–22.
Fonarow, G C, Smith, E E, Saver, J L, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: Patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011; 7:750–8.
Mishra, N K, Ahmed, N, Andersen, G, et al. VISTA collaborators; SITS collaborators. Thrombolysis in very elderly people: Controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010; 341:c6046. doi:10.1136.
Intracerebral haemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997; 11: 2109–18.
Saposni, G, Raptis, S, Kapral, M K, et al. Investigators of the Registry of the Canadian Stroke Network and the Stroke Outcome Research Canada Working Group. The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke. Stroke. 2011; 12:3421–8.
Saposnik, G, Fang, J, Kapral, M K, et al. Investigators of the Registry of the Canadian Stroke Network (RCSN); Stroke Outcomes Research Canada (SORCan) Working Group. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012; 5:1315–22.
Mazya, M, Egido, J A, Ford, G A, et al. SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: Safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012; 43:1524–31.
Mazya, M V, Bovi, P, Castillo, J, et al. External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis. Stroke. 2013; 44:1595–600.
Butcher, K, Christensen, S, Parsons, M, et al. EPITHET Investigators. Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke. 2010; 1:72–7.
Diedler, J, Ahmed, N, Sykora, M, et al. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Stroke. 2010; 2:288–94.
Martinez-Ramirez, S, Delgado-Mederos, R, Marín, R, et al. Statin pretreatment may increase the risk of symptomatic intracranial haemorrhage in thrombolysis for ischemic stroke: Results from a case-control study and a meta-analysis. J Neurol. 2012; 1:111–18.
Diedler, J, Ahmed, N, Glahn, J, et al. Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg? Stroke. 2011; 6:1615–20.
Putaala, J, Sairanen, T, Meretoja, A, et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis. 2011; 1:8392.
Mustanoja, S, Meretoja, A, Putaala, J, et al. Helsinki Stroke Thrombolysis Registry Group. Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke. 2011; 1:102–6.
Qureshi, A I, Chaudhry, S A, Hassan, A E, et al. Thrombolytic treatment of patients with acute ischemic stroke related to underlying arterial dissection in the United States. Arch Neurol. 2011; 12:1536–42.
Mazya, M V, Ahmed, N, Ford, G A, et al. Remote or extraischemic intracerebral hemorrhage – an uncommon complication of stroke: Results from the Safe Implementation of Treatments in Stroke – International Stroke Thrombolysis Register. Stroke. 2014; 45:1657–63.
Castellanos, M, Sobrino, T, Millán, M, et al. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study. Stroke. 2007; 6:1855–914.
Albers, G W, Thijs, V N, Wechsler, L, et al. DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: The Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study. Ann Neurol. 2006; 5:508–17.
Campbell, B C, Christensen, S, Butcher, K S, et al. EPITHET Investigators. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke. 2010; 1:82–8.
Fiehler, J, Albers, G W, Boulanger, J M, et al. MR STROKE Group. Bleeding Risk Analysis in Stroke Imaging before thromboLysis (BRASIL): Pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007; 2738–44.
Dannenberg, S, Scheitz, J F, Rozanski, M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke. 2014; 10:2900–5.
Gratz, P P, El-Koussy, M, Hsieh, K, et al. Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke. 2014; 6:1684–8.
Jung, S, Mono, M L, Findling, O, et al. White matter lesions and intra-arterial thrombolysis. J Neurol. 2012; 7:1331–6.
Neumann-Haefelin, T, Hoelig, S, Berkefeld, J, et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke. 2006; 37: 2463–6.
Broderick, J P, Palesch, Y Y, Demchuk, A M, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 368:893903.
Kidwell, C S, Jahan, R, Saver, J L. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 368:2434–5.
Ciccone, A, Valvassori, L, Nichelatti, M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 368:904–13.
Berkhemer, O A, Fransen, P S, Beumer, D, et al. MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015; 1:1120.
Goyal, M, Demchuk, A M, Menon, B K, et al. ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 11:1019–30.
Saver, J L, Goyal, M, Bonafe, A, et al. SWIFT PRIME Investigators. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: Protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke. 2015; 3:439–48.
Campbell, B C, Mitchell, P J, Kleinig, T J, et al. EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015; 11:1009–18.
Bang, O Y, Saver, J L, Kim, S J, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke. 2011; 42:2235–9.
Warach, S, Latour, L L. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood–brain barrier disruption. Stroke. 2004; 35:2659–61.
Khatri, R, McKinney, A M, Swenson, B, et al. Blood–brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. Neurology. 2012; 79:S52–7.
Giraud, M, Cho, T H, Nighoghossian, N, et al. Early blood brain barrier changes in acute ischemic stroke: A sequential MRI study. J Neuroimaging. 2015; 25:959–63.

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×